NEWS
HOMENEWS
- 2024.10.04(Scheduled for Oct. 29) Senior Investigator to Present at CBI Annual Meeting 2024
- 2024.09.05(Report) Representative Nakamura present at “JASIS Collaboration – Public Utilization Platform Brings Innovation to Research” hosted by MEXT
- 2024.08.21CEO Nakamura to present at “JASIS Collaboration; Public utilization platform brings innovation to research ~Measurement and analysis systems open up new research horizons~” hosted by MEXT on Sep. 4
- 2024.08.15Announcement of Participation in “Japan Healthcare Venture Summit 2024”
- 2024.06.19Veritas In Silico Announces Milestone Achievement in Collaborative Research with Takeda
- 2024.03.12Senior investigator to present at a webinar series hosted by Oncodesign Services on March 27
- 2024.03.01New publication on the applications of artificial intelligence in RNA-targeted small molecule drug discovery
- 2024.02.08Veritas In Silico Listed on the Growth Market of the Tokyo Stock Exchange
- 2023.12.21RaQualia Pharma and Veritas In Silico announce that both companies have achieved the milestone in a joint research collaboration for mRNA-targeted small molecule drug discovery
- 2023.12.08Mitsubishi Gas Chemical and Veritas In Silico start to discuss the research collaboration of RNA targeting drug discovery program
- 2023.11.22Joint publication with Professor Fukuzawa comes out in the latest issue of ACS Chemical Biology
- 2023.07.28Senior Investigator Morishita to be an invited speaker at the RNA Assay Development & Screening Summit on August 24
- 2023.06.23Veritas In Silico and Takeda Enter Into Collaborative Research and License Agreement for mRNA-Targeted Small Molecule Drugs
- 2023.05.22Oncodesign Services and Veritas In Silico enter into business cooperation on developing mRNA-targeted small molecule drugs
- 2022.12.27RaQualia Pharma and Veritas in Silico enter into a new joint research agreement for mRNA-targeted small molecule drug discovery
- 2022.10.04Veritas In Silico Begins RNase-Recruiting Small Molecule Screening for RIBOTAC Design and Synthesis
- 2021.12.27Veritas In Silico Announces 1.4 Billion JPY (Approx. $12.2 Million) Series C Financing
- 2021.11.25Veritas in Silico Signs Joint Drug Discovery Research Agreement with Shionogi
- 2021.09.02Veritas In Silico and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based RNA-Targeting Small Molecule Drug Discovery
- 2021.07.28Toray and Veritas in Silico Sign Joint Drug Discovery Research Agreement
